COMMUNIQUÉS West-GlobeNewswire

Elite Pharmaceuticals Files ANDA for Codeine and Acetaminophen Combo
18/09/2018
NORTHVALE, N.J., Sept. 18, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP) a specialty pharmaceutical company developing abuse-deterrent opioids and niche generic products, [...]
Valeria Robinson-Baker, B.S.Pharm., R.Ph., C.Ph., is Appointed to the American Health Council’s Industry Board
18/09/2018
NEW YORK, Sept. 18, 2018 (GLOBE NEWSWIRE) -- The American Health Council appoints Valeria Robinson-Baker, B.S.Pharm., R.Ph., C.Ph., to its Industry Board. A supervisor of the Non-Sterile Compounding and Hazardous Drugs [...]
Foamix Announces Closing of its Follow-on Offering of Ordinary Shares and Full Exercise of its Option by the Underwriters
18/09/2018
REHOVOT, Israel, and BRIDGEWATER, N.J., Sept. 18, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (“Foamix”) (Nasdaq: FOMX), a clinical-stage specialty pharmaceutical company focused on developing and [...]
Medtronic Announces Clinical Study of Transcatheter Aortic Valve Replacement in Aortic Stenosis Patients with Bicuspid Valves
18/09/2018
Medtronic Receives FDA Approval for Revised TAVR Labeling and Begins Investigational Study of Low Risk Patients with Bicuspid Valves DUBLIN - September 18, 2018 - Medtronic plc (NYSE:MDT) today announced that the U.S. [...]
Emblem and Canntab to Commence Clinical Testing of 12-Hour Extended Release Cannabis Tablets
18/09/2018
TORONTO, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”), through its wholly-owned subsidiary Emblem Cannabis Corporation, a licensed producer of medical cannabis [...]
NewLink Genetics to Participate in the Cantor Global Healthcare Conference
18/09/2018
AMES, Iowa, Sept. 18, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) announced today that the Company will present at the 2018 Cantor Global Healthcare Conference on Wednesday, October 3, 2018, at 4 [...]
PHM Announces Accretive Acquisition of Respiratory Services Focused Business
18/09/2018
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. CINCINNATI, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Protech Home [...]
Phoenix Life Sciences International Completes Merger and Announces Global Production Strategy
18/09/2018
DENVER, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Phoenix Life Sciences International Limited (“Phoenix Life”), an adaptive healthcare solutions company, today announced its common stock is now publicly traded in the United [...]
Q-Apps Now Listed in the Epic App Orchard to Achieve Easier Data Interoperability
18/09/2018
App Orchard process streamlines access to health record information that significantly increases efficiency and value of Q-Centrix quality solutions for hospitals and health systems. Chicago, Sept. 18, 2018 (GLOBE [...]
ContraVir Pharmaceuticals Announces Completion of Phase 1 with CRV431
18/09/2018
EDISON, N.J., Sept. 18, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercialization of therapeutic drugs for the treatment of [...]
BioAegis Therapeutics Enrolls First Patients in Phase 1b/2a Community-Acquired Pneumonia Study and Raises $4 MM in Equity Round
18/09/2018
MORRISTOWN, N.J., Sept. 18, 2018 (GLOBE NEWSWIRE) -- BioAegis Therapeutics Inc. announced that it has begun patient enrollment in a Phase 1b/2a study of recombinant plasma gelsolin (rhu-pGSN) in Community-Acquired [...]
Acasti Pharma Provides Clinical and Market Update
18/09/2018
TRILOGY phase 3 studies exceed 75% enrollment; on track to report topline results in 2019 LAVAL, Quebec, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator [...]
CBT Pharmaceuticals Initiates the APOLLO Oncology Clinical Trials Program
18/09/2018
First Patient Dosed in Initial Immunotherapy Combination Trial Utilizing CBT’s Proprietary Assets PLEASANTON, Calif. and HANGZHOU, China, Sept. 18, 2018 (GLOBE NEWSWIRE) -- CBT Pharmaceuticals (CBT), a U.S. and China- [...]
Avisa Reports on Progress with Biomarker AV BreathTest™ Platform
18/09/2018
Ten-minute, point-of-care breath test rapidly detects virulent bacterial infections to mitigate overuse of antibiotics and save hospital costs Proof-of-concept trial in Emergency Department pneumonia expected to be [...]
Hemispherx to Distribute Second Lot of Ampligen® for use in Multiple Indications in Argentina, the United States and Europe
18/09/2018
Ampligen supply will support product launch in Argentina, Expanded Access Programs for the treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in the United States and Europe and pancreatic cancer in the [...]
ARCA biopharma Submits Special Protocol Assessment Request to FDA for Gencaro Phase 3 Atrial Fibrillation Clinical Trial
18/09/2018
Gencaro potentially the first genetically-targeted treatment for heart failure patients at risk for atrial fibrillation PRECISION-AF, planned Phase 3 clinical trial in patients with genotype that responds most favorably [...]
Agritek Holdings, Inc. Announces Filing Of Form 10-Q Report With Return To Fully Reporting Status On OTCQB And Update To Shareholders
18/09/2018
LOS ANGELES, CA, Sept. 18, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Agritek Holdings, Inc. (OTCQB: AGTK) www.AgritekHoldings.com , a fully integrated, active real estate investor for the cannabis sector in the [...]
Wildflower Store Opening in New York’s Iconic Times Square in November
18/09/2018
VANCOUVER, British Columbia, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Wildflower Brands Inc. (CSE: SUN , OTC: WLDFF ) (the “ Company ”) is excited to announce that design work is completed for three prime locations in [...]
Cancer Genetics and NovellusDx Sign Definitive Agreement to Merge
18/09/2018
Transaction to Create a Leader in Precision Oncology RUTHERFORD, N.J. and JERUSALEM, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology [...]

Pages